Aster DM Healthcare Unsecured Creditors Meeting Approves Amalgamation Scheme

The meeting of Unsecured Trade Creditors of Aster DM Healthcare Limited approved the Scheme of Amalgamation between Aster DM Healthcare Limited and Quality Care India Limited. The amalgamation resolution received the necessary approvals during the meeting held on March 10, 2026, conducted through video conferencing. Unsecured Trade Creditors exercised their voting rights through remote e-voting and e-voting at the meeting.

Amalgamation Scheme Approval

The Scheme of Amalgamation amongst Quality Care India Limited (“QCIL”) and Aster DM Healthcare Limited has been approved by the Unsecured Trade Creditors. As per the directions of the Hon’ble National Company Law Tribunal, Hyderabad Bench, the meeting was conducted on March 10, 2026, via video conferencing.

Voting Details

A notice was issued to the Unsecured Trade Creditors, providing details on the meeting and voting procedures. Remote e-voting started on March 6, 2026, and concluded on March 9, 2026. The cut-off date for ascertaining Unsecured Trade Creditors entitled to vote was October 31, 2025.

Rationale for Amalgamation

The amalgamation aims to create a stronger healthcare entity with benefits including:

Scale and Financial Resilience: A merged entity is projected to become among the top 3 hospital chains in India.

Diversification and Growth: Diversified presence across 9 states and 25 cities in India is expected.

Synergies: The proposal aims to improve revenue, supply chain efficiencies, and integrated doctor models.

Key Terms of the Scheme

Upon the scheme effectiveness, QCIL will be amalgamated into Aster. For every 1,000 shares of QCIL, 977 equity shares of Aster DM will be issued.

Stakeholder Impact

The scheme will allow the company to issue shares to eligible QCIL shareholders. All employees of QCIL will be transferred to Aster DM. No material adverse effect is expected on stakeholders.

Approvals and Next Steps

The Hon’ble NCLT, along with other regulatory authorities, still need to grant sanction. An approval from the Competition Commission of India (CCI) has been received.

Source: BSE

Previous Article

JK Cement Analyst/Institutional Investor Meeting Scheduled for February 10-11, 2026

Next Article

Archean Chemical Industries Board Approves Q3 2026 Results